Globus Medical Inc. (GMED) stock falls, “Hold” rating reiterated by Canaccord Genuity Analysts

Globus Medical Inc. (NYSE: GMED) shares fell on Monday January 23 on lower trade volume than normal after a number of analysts weighed in on the investing value of the stock and reiterated thier respective ratings.

Meanwhile, U.S. stocks flipped between small gains and losses in early trade on Monday.

The Dow Jones Industrial Average DJIA, -0.14% was off by 13 points, or less than 0.1%, at 19,815, with McDonald’s Corp MCD, -0.99% and General Electric CoGE, -0.95% leading the losses, down more than 1%.

The S&P 500 SPX, -0.18% slipped 2 point to 2,270, with five of the main sectors trading lower. The Nasdaq Composite COMP, -0.09% gained 4 points to 5,558.

Canaccord Genuity analysts reiterated its Hold rating on Globus Medical Inc. (NYSE: GMED) in a note to investors, making it one of the more closely watched stocks on Wall Street. Canaccord Genuity currently has a rating of Hold on the stock. The one-year price target of $25.80 is lower than the opening price of $26.09, resulting a number of other analysts to comment on the company in recent days. Looking back over the last year, Globus Medical Inc. stock has a high of $27.66. Share prices sometimes get a spike to the upside when analysts reiterate coverage.

Shares of Globus Medical Inc. (NYSE: GMED) opened at $26.09 yesterday and traded in a range between, $26.01 and $26.39, and last traded at $26.07, which is a decrease of $0.10 compared to the previous closing price.

Globus Medical Inc. (NYSE: GMED) currently has a market cap of 2.50B.

Globus Medical Inc. (NYSE: GMED) Average Daily Trading Volume

The stock’s average daily volume is 1,211,700 shares out of a total float 69,553,000 and some 29,642 shares crossed the trading desk yesterday, 122 percent below normal. lower than normal. Look for trading volume to pick up in the coming days as investors often use increases in trading volume to identify heavy volume accumulation or distribution by institutional investors.

However, a single day of heavy buy side trading is not enough to assert a trend. As such, market traders will continue to watch for institutional sponsorship as a signal that financial institutions are moving forward.

Institutional sponsorship is defined by ownership of a stock by mutual funds, banks, pension funds and other large institutions.

These professional investors have substantial teams of analysts that research thousands of stocks, so it is good validation to see them buying a stock you’re researching.

Globus Medical Inc. (NYSE: GMED) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

By tracking the activity of these professional investors—and the moving averages they affect—it allows for traders to make more effective decisions on trades.

With that in mind, Globus Medical Inc. (NYSE: GMED) now has a 50-day MA of $24.77 and 200-day MA of $23.37. It has traded in a 52-week range between $19.25 – 27.66 and today’s last price is 5.75%% lower than the 52 week high of $27.66.

Indeed, earnings growth is among the most crucial things to look at in regards to stock investing and, accordingly, investors look for companies that have increased their earnings by at least 25% for 3 consecutive years.

DISCLOSURE: The views and opinions expressed in this article do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Latest News

Leave a Reply